Isolating Mechanisms in the Treatment of Borderline Personality Disorder
Borderline Personality Disorder
About this trial
This is an interventional treatment trial for Borderline Personality Disorder
Eligibility Criteria
Inclusion Criteria:
- Diagnostic and Statistical Manual (5th Edition; DSM-5) diagnosis of borderline personality disorder;
- willing to maintain a stable dose on prescribed psychotropic medication throughout the study duration. This avoids problems with reluctance to discontinue or difficulty with discontinuing, and also the confounding of outcomes from initiation of medication during treatment; this procedure is a longstanding practice at the Center for Anxiety and Related Disorders (CARD) at Boston University for treatment outcome research. Additionally, participants must be
- fluent in English.
Exclusion Criteria:
In order to maximize generalizability, exclusion criteria are based solely on the well-being of the participant and will consist primarily of conditions that would require prioritization for immediate treatment (e.g., severe suicidality or substance dependence). These include:
- Current DSM-5 diagnoses of bipolar disorder, schizophrenia, schizoaffective disorder, or organic mental disorder;
- Clear and current suicidal risk (intent);
- Current or recent (within 3 months) history of drug dependence;
- Willingness to refrain from additional psychosocial treatment across the course of the study; and
- has access to own smartphone.
Sites / Locations
- Boston University Center for Anxiety and Related Disorders
Arms of the Study
Arm 1
Arm 2
Other
Other
2-week baseline
4-week baseline
Patients complete assessment only for a duration of 2-weeks prior to starting the intervention: Countering Emotional Behaviors Module from the Unified Protocol.
Patient complete assessment only for a duration of 4-weeks prior to starting the intervention: Countering Emotional Behaviors Module from the Unified Protocol.